Jefferies Group LLC Amylyx Pharmaceuticals, Inc. Call Options Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
Call Options
1 transactions
Others Institutions Holding AMLX
# of Institutions
184Shares Held
50.3MCall Options Held
5.84MPut Options Held
2.06M-
Vanguard Group Inc Valley Forge, PA5.35MShares$10.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$8.41 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.94MShares$5.53 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.47MShares$4.65 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.07MShares$3.89 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $110M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...